Blagden, Sarah P ;
Billingham, Lucinda ;
Brown, Louise C...
Blagden , S P , Billingham , L , Brown , L C , Buckland , S W , Cooper , A M , Ellis , S , Fisher , W , Hughes , H , Keatley , D A , Maignen , F M , Morozov , A , Navaie , W , Pearson , S , Shaaban , A , Wydenbach , K , Kearns , P R , Abouzeid , C , Ahmed , R , Bailey , S , Blewett , C , Campbell , H , Cerone , M A , Clack , G , Cook , N , Ghiorghiu , S , Halford , S , Johnston , A , Kaplan , R , Lawson , A , Lowe , E , Mathews , J , Mirabile , I , Osipenko , L , Patel , D , Potter , C , Regan , A , Ricamara , M , Ringrose , C , Rodger , J , Sandhu , G K , Schiavone , F , Silvester , J , Sydes , M R , Weller , C & Yiangou , A 2020 , ' Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statement ' , British Journal of Cancer , vol. 122 , no. 4 , pp. 473-482 . https://doi.org/10.1038/s41416-019-0653-9.
,
2020
